Long-Term Clinical Outcomes After Everolimus- and Sirolimus-Eluting Coronary Stent Implantation
Author(s) -
Hiroki Shiomi,
Ken Kozuma,
Takeshi Morimoto,
Keiichi Igarashi,
Kazushige Kadota,
Kengo Tanabe,
Yoshihiro Morino,
Takashi Akasaka,
Mitsuru Abe,
Satoru Suwa,
Toshiya Muramatsu,
Masakazu Kobayashi,
Kazuoki Dai,
Kōichi Nakao,
Masaaki Uematsu,
Yasuhiro Tarutani,
Kenshi Fujii,
Charles A. Simonton,
Takeshi Kimura
Publication year - 2014
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.113.001322
Subject(s) - medicine , cumulative incidence , stent , myocardial infarction , sirolimus , cardiology , everolimus , target lesion , lesion , revascularization , clinical endpoint , thrombosis , incidence (geometry) , surgery , randomized controlled trial , percutaneous coronary intervention , cohort , physics , optics
Long-term clinical outcomes of everolimus-eluting stent (EES) compared with sirolimus-eluting stent (SES) have not been evaluated fully yet, especially whether EES implantation could positively affect late adverse events reported after SES implantation occurring >1 year.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom